 White House Initiative on Women’s Health Research Workshop
In collaboration with the White House Gender Policy Council, NIH held a workshop on October 29, 2024 at the White House to showcase how NIH is harnessing interdisciplinary research and innovation to accelerate and improve health for all women. NIH leadership, Institute and Center Directors, and members of the women's health research community came together in this workshop which highlighted NIH interdisciplinary research advancements for women across the lifespan and explored the potential and promise of women’s health research.
Learn more
These awards will fund research on chronic conditions that are understudied among women and/or that disproportionately affect populations of women who are understudied, underrepresented, and underreported in biomedical research.
Learn More
This year’s BIRCWH Scholars presented innovative research on topics such as genome-wide associations, gene expression, military sexual trauma, and placental programming of infant health.
Learn More
R56 awards support short-term, highly meritorious extramural research that falls just outside the funding limits of participating NIH institutes and centers (ICs).
Learn More
Read In the Spotlight Articles
Advancing Health Equity through Interventions to Prevent and Address Housing Instability (R01 Clinical Trial Optional) (RFA-NR-25-001)
Expiration date: December 14, 2024
Notice of ORWH's Participation in PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications
(PA-24-247), (PA-24-248)
Due dates: January 5, 2025
Notice of ORWH's Participation in PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (PA-24-245), (PA-24-246)
Due dates: January 5, 2025
Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations
(PAR-25-213), (PAR-25-223)
First available due dates: January 7, 2025
NOSI: Research on the Health of Women of Underrepresented, Underserved, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional) (NOT-OD-24-179)
First available due date: January 22, 2025
|
